Raymond James Financial’s Insulet PODD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$37.9M Sell
249,250
-8,476
-3% -$1.41M 0.01% 1094
2026
Q1
$53.8M Sell
257,726
-113,890
-31% -$28.6M 0.02% 813
2025
Q4
$106M Sell
371,616
-25,044
-6% -$7.83M 0.03% 480
2025
Q3
$122M Buy
396,660
+44,316
+13% +$13.9M 0.04% 427
2025
Q2
$111M Buy
352,344
+2,644
+0.8% +$763K 0.04% 447
2025
Q1
$91.8M Buy
349,700
+83,743
+31% +$22.7M 0.03% 465
2024
Q4
$69.4M Buy
+265,957
New +$67M 0.03% 558

Other funds holding PODD

Raymond James Financial's PODD Position: Q2 2026 in Review

Raymond James Financial reduced its Insulet (PODD) stake by 3.3% in Q2 2026, selling an estimated $1.41M and leaving 249,250 shares worth $37.9M. The position accounts for 0.01% of the portfolio, ranked #1094.

Raymond James Financial first reported a position in PODD in Q4 2024 and has held it in 7 quarters since. The position peaked at $122M in Q3 2025. 731 funds tracked by Wall St. Rank hold PODD as of Q2 2026.

  • Raymond James Financial held 249,250 shares of Insulet worth $37.9M as of Q2 2026.
  • Raymond James Financial sold 8,476 Insulet shares in Q2 2026, an estimated $1.41M.
  • Insulet made up 0.01% of Raymond James Financial's portfolio in Q2 2026, its #1094 holding.
  • Raymond James Financial first reported a position in Insulet in Q4 2024 and has held it in 7 quarters since.
  • Raymond James Financial's Insulet position peaked at $122M in Q3 2025.
  • 731 funds tracked by Wall St. Rank held Insulet as of Q2 2026.

Based on Raymond James Financial's 13F filing for Q2 2026, filed 14 Aug 2026.